Actuate Therapeutics ACTU
NASDAQ ACTU
$0.62 +0.02 (+2.85%)
At close: Oct 20, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Income Taxes Paid (2024 - 2025)

Updated

Analysis

Actuate Therapeutics (ACTU) Income Taxes Paid (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes Paid (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 398.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 2.58 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 3.47 Bn
10 Actuate Therapeutics 14.74 Mn -26.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 800.00
Sep 30, 2024 800.00
API Access

Actuate Therapeutics Income Taxes Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-taxes-paid&ticker=ACTU&period=max&api_key=YOUR_API_KEY